State Street
OPRX icon

State Street’s OptimizeRx OPRX Stock Holding History

State Street’s Portfolio OPRX Stock Details OPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3M Buy
477,780
+249
+0.1% +$2.31K ﹤0.01% 3167
2025
Q4 		$5.85M Buy
477,531
+84,808
+22% +$1.39M ﹤0.01% 2924
2025
Q3 		$8.05M Buy
392,723
+3,691
+0.9% +$58.6K ﹤0.01% 2753
2025
Q2 		$5.25M Buy
389,032
+29,513
+8% +$323K ﹤0.01% 2921
2025
Q1 		$3.11M Buy
359,519
+2,656
+0.7% +$16.2K ﹤0.01% 3068
2024
Q4 		$1.73M Buy
356,863
+6,770
+2% +$37.8K ﹤0.01% 3361
2024
Q3 		$2.7M Buy
350,093
+1,811
+0.5% +$16.1K ﹤0.01% 3218
2024
Q2 		$3.48M Buy
348,282
+13,443
+4% +$148K ﹤0.01% 3082
2024
Q1 		$4.07M Buy
334,839
+14,280
+4% +$207K ﹤0.01% 3009
2023
Q4 		$4.59M Sell
320,559
-165,259
-34% -$1.59M ﹤0.01% 2986
2023
Q3 		$3.78M Sell
485,818
-6,253
-1% -$68K ﹤0.01% 3062
2023
Q2 		$7.03M Buy
492,071
+69,169
+16% +$985K ﹤0.01% 2826
2023
Q1 		$6.19M Sell
422,902
-277,997
-40% -$4.65M ﹤0.01% 2909
2022
Q4 		$11.8M Buy
700,899
+21,201
+3% +$367K ﹤0.01% 2599
2022
Q3 		$10.1M Buy
679,698
+19,815
+3% +$392K ﹤0.01% 2709
2022
Q2 		$18.1M Buy
659,883
+54,484
+9% +$1.61M ﹤0.01% 2327
2022
Q1 		$22.8M Buy
605,399
+10,945
+2% +$484K ﹤0.01% 2299
2021
Q4 		$36.9M Buy
594,454
+279,640
+89% +$21.2M ﹤0.01% 2025
2021
Q3 		$26.9M Buy
314,814
+8,863
+3% +$556K ﹤0.01% 2264
2021
Q2 		$18.9M Buy
305,951
+31,941
+12% +$1.63M ﹤0.01% 2552
2021
Q1 		$13.4M Buy
274,010
+20,740
+8% +$1M ﹤0.01% 2603
2020
Q4 		$7.89M Buy
253,270
+3,539
+1% +$86.7K ﹤0.01% 2754
2020
Q3 		$5.21M Sell
249,731
-1,032
-0.4% -$17.7K ﹤0.01% 2757
2020
Q2 		$3.27M Buy
250,763
+6,295
+3% +$68.4K ﹤0.01% 2977
2020
Q1 		$2.21M Buy
244,468
+5,559
+2% +$52.7K ﹤0.01% 3022
2019
Q4 		$2.45M Buy
238,909
+7,244
+3% +$82.1K ﹤0.01% 3176
2019
Q3 		$3.35M Buy
231,665
+62,105
+37% +$961K ﹤0.01% 2988
2019
Q2 		$1.77M Buy
+169,560
New +$2.29M ﹤0.01% 3289

Other funds holding OPRX

WCA
Whetstone Capital Advisors Shawnee Mission, Kansas $288M AUM 44.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
PHP
Parkman Healthcare Partners Stamford, Connecticut $970M AUM 79.46% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
KCM
Kennedy Capital Management St Louis, Missouri $4.72B AUM 36.69% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street's OPRX Position: Q1 2026 in Review

State Street increased its OptimizeRx (OPRX) stake by 0.05% in Q1 2026, buying an estimated $2.31K and bringing the position to 477,780 shares worth $3M. The position accounts for ﹤0.01% of the portfolio, ranked #3167.

State Street first reported a position in OPRX in Q2 2019 and has held it in 28 quarters since. The position peaked at $36.9M in Q4 2021. 128 funds tracked by Wall St. Rank hold OPRX as of Q1 2026.

  • State Street held 477,780 shares of OptimizeRx worth $3M as of Q1 2026.
  • State Street bought 249 OptimizeRx shares in Q1 2026, an estimated $2.31K.
  • OptimizeRx made up ﹤0.01% of State Street's portfolio in Q1 2026, its #3167 holding.
  • State Street first reported a position in OptimizeRx in Q2 2019 and has held it in 28 quarters since.
  • State Street's OptimizeRx position peaked at $36.9M in Q4 2021.
  • 128 funds tracked by Wall St. Rank held OptimizeRx as of Q1 2026.

Based on State Street's 13F filing for Q1 2026, filed 15 May 2026.